ArticleThe patient2013

The patient journey in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapies: qualitative insights using a global ethnographic approach.

François Guilhot et al.PubMed ↗Publisher ↗

No numbers read from the abstract.